Lilly

Seamless Therapeutics Enters $1.12 Billion Global Research Collaboration with Eli Lilly to Develop Therapeutics for Hearing Loss

admin February 1, 2026 0

Seamless Therapeutics entered into a strategic global research collaboration and licensing agreement with Eli Lilly and Company to develop and...

Seamless Therapeutics Announces Global Research Collaboration with Lilly to Develop Programmable Recombinase-based Therapeutics for Hearing Loss

admin January 30, 2026 0

Seamless Therapeutics -- Collaboration will advance a next generation gene editing approach by combining Seamless’ expertise in developing highly precise...

Research Collaboration

United States – Goodwin Represents Nimbus Therapeutics In Research Collaboration And License Agreement With Lilly For Novel Oral Obesity Treatment For Up To $1.3 Billion

admin January 18, 2026 0

GP Goodwin Procter LLP More At Goodwin, we partner with our clients to practice...

Nimbus Therapeutics Announces Research Collaboration and License Agreement with Lilly for Novel Oral Obesity Treatment

admin January 11, 2026 0

-- New collaboration follows previous Lilly and Nimbus AMPK research collaboration in cardiometabolic disease -- BOSTON, January 06, 2026--(BUSINESS WIRE)--Nimbus...

ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly

admin December 31, 2025 0

- Secured a total of 55 million in R&D funding, including 40 million in upfront payment and 15 million in...

Lila Biologics Announces Collaboration with Lilly For

admin September 8, 2025 0

Seattle, WA, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Lila Biologics (“Lila”), an AI/ML-driven protein therapeutics biotech company, today announced a...

Lilly

Seamless Therapeutics Enters $1.12 Billion Global Research Collaboration with Eli Lilly to Develop Therapeutics for Hearing Loss

Seamless Therapeutics Announces Global Research Collaboration with Lilly to Develop Programmable Recombinase-based Therapeutics for Hearing Loss

United States – Goodwin Represents Nimbus Therapeutics In Research Collaboration And License Agreement With Lilly For Novel Oral Obesity Treatment For Up To $1.3 Billion

Nimbus Therapeutics Announces Research Collaboration and License Agreement with Lilly for Novel Oral Obesity Treatment

ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly

Lila Biologics Announces Collaboration with Lilly For

IEEE Course Improves Technical Writing Skills

DVIDS – News – A new era of maritime excellence: an update on the Mariner Skills Training Centers

Build AI skills: Google AI Professional Certificate

Crossroads Barrie Answers Canada’s Professional Driver Shortage with Versatile Driver Training Programs

IPB University and Simon Fraser University Discuss Research Collaboration, Double Degree, and Student Mobility

You may have missed